Biomarkers of acute kidney injury and associations with shortand long-term outcomes.

F1000Research

Volumn 5, Issue , 2016, Pages

  Schaub, Jennifer A ^a   Parikh, Chirag R ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; EPIDERMAL GROWTH FACTOR; FATTY ACID BINDING PROTEIN; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; LIVER FATTY ACID BINDING PROTEIN; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SCATTER FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; CARDIORENAL SYNDROME; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; EMERGENCY WARD; GLOMERULUS FILTRATION RATE; HEART SURGERY; HOSPITAL PATIENT; HUMAN; KIDNEY TRANSPLANTATION; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PROGNOSIS; REVIEW; URINE LEVEL;

EID: 85010886849     PISSN: None     EISSN: 20461402     Source Type: Journal    
DOI: 10.12688/F1000RESEARCH.7998.1     Document Type: Review

References (74)

1. Uchino S, Kellum JA, Bellomo R, et al.: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005; 294(7): 813-8.
2. Bagshaw SM, Uchino S, Bellomo R, et al.: Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2007; 2(3): 431-9.
3. Coca SG, Yusuf B, Shlipak MG, et al.: Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and metaanalysis. Am J Kidney Dis. 2009; 53(6): 961-73.
4. Coca SG, King JT Jr, Rosenthal RA, et al.: The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int. 2010; 78(9): 926-33.
5. Uchino S, Bellomo R, Bagshaw SM, et al.: Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant. 2010; 25(6): 1833-9.
6. Grams ME, Rabb H: The distant organ effects of acute kidney injury. Kidney Int. 2012; 81(10): 942-8.
7. Chen HH, Anstrom KJ, Givertz MM, et al.: Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013; 310(23): 2533-43.
8. Garg AX, Kurz A, Sessler DI, et al.: Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. JAMA. 2014; 312(21): 2254-64.
9. Hausenloy DJ, Candilio L, Evans R, et al.: Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery. N Engl J Med. 2015; 373(15): 1408-17.
10. Whitlock RP, Devereaux PJ, Teoh KH, et al.: Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet. 2015; 386(10000): 1243-53.
11. Chen HH, AbouEzzeddine OF, Anstrom KJ, et al.: Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial. Circ Heart Fail. 2013; 6(5): 1087-94.
12. Hsu CY, Hsu RK, Yang J, et al.: Elevated BP after AKI. J Am Soc Nephrol. 2016; 27(3): 914-23.
13. Pechman KR, De Miguel C, Lund H, et al.: Recovery from renal ischemiareperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodium-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol. 2009; 297(5): R1358-63.
14. Spurgeon-Pechman KR, Donohoe DL, Mattson DL, et al.: Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium. Am J Physiol Renal Physiol. 2007; 293(1): F269-78.
15. Coca SG, Singanamala S, Parikh CR: Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012; 81(5): 442-8.
16. Chawla LS, Amdur RL, Shaw AD, et al.: Association between AKI and longterm renal and cardiovascular outcomes in United States veterans. Clin J Am Soc Nephrol. 2014; 9(3): 448-56.
17. Canaud G, Bonventre JV: Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury. Nephrol Dial Transplant. 2015; 30(4): 575-83.
18. Yang L, Besschetnova TY, Brooks CR, et al.: Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med. 2010; 16(5): 535-43, 1p following 143.
19. Burchill L, Velkoska E, Dean RG, et al.: Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression. Exp Physiol. 2008; 93(5): 622-30.
20. Kelly KJ: Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol. 2003; 14(6): 1549-58.
21. Tokuyama H, Kelly DJ, Zhang Y, et al.: Macrophage infiltration and cellular proliferation in the non-ischemic kidney and heart following prolonged unilateral renal ischemia. Nephron Physiol. 2007; 106(3): p54-62.
22. Robinson SC, Bowmer CJ, Yates MS: Cardiac function in rats with acute renal failure. J Pharm Pharmacol. 1992; 44(12): 1007-14.
23. Han WK, Bailly V, Abichandani R, et al.: Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002; 62(1): 237-44.
24. Melnikov VY, Ecder T, Fantuzzi G, et al.: Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest. 2001; 107(9): 1145-52.
25. Melnikov VY, Faubel S, Siegmund B, et al.: Neutrophil-independent mechanisms of caspase-1-and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest. 2002; 110(8): 1083-91.
26. Mishra J, Ma Q, Prada A, et al.: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003; 14(10): 2534-43.
27. Go AS, Parikh CR, Ikizler TA, et al.: The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol. 2010; 11: 22.
28. Coca SG, Garg AX, Thiessen-Philbrook H, et al.: Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J Am Soc Nephrol. 2014; 25(5): 1063-71.
29. Haase M, Devarajan P, Haase-Fielitz A, et al.: The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol. 2011; 57(17): 1752-61.
30. Parikh CR, Coca SG, Thiessen-Philbrook H, et al.: Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol. 2011; 22(9): 1748-57.
31. Parikh CR, Thiessen-Philbrook H, Garg AX, et al.: Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol. 2013; 8(7): 1079-88.
32. Koyner JL, Garg AX, Shlipak MG, et al.: Urinary cystatin C and acute kidney injury after cardiac surgery. Am J Kidney Dis. 2013; 61(5): 730-8.
33. Arthur JM, Hill EG, Alge JL, et al.: Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery. Kidney Int. 2014; 85(2): 431-8.
34. Alge JL, Karakala N, Neely BA, et al.: Association of elevated urinary concentration of renin-angiotensin system components and severe AKI. Clin J Am Soc Nephrol. 2013; 8(12): 2043-52.
35. Meersch M, Schmidt C, van Aken H, et al.: Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One. 2014; 9(3): e93460.
36. Zhang WR, Garg AX, Coca SG, et al.: Plasma IL-6 and IL-10 Concentrations Predict AKI and Long-Term Mortality in Adults after Cardiac Surgery. J Am Soc Nephrol. 2015; 26(12): 3123-32.
37. Calfee CS, Delucchi K, Parsons PE, et al.: Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014; 2(8): 611-20.
38. Siew ED, Ikizler TA, Gebretsadik T, et al.: Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clin J Am Soc Nephrol. 2010; 5(8): 1497-505.
39. Siew ED, Ware LB, Bian A, et al.: Distinct injury markers for the early detection and prognosis of incident acute kidney injury in critically ill adults with preserved kidney function. Kidney Int. 2013; 84(4): 786-94.
40. Siew ED, Ware LB, Gebretsadik T, et al.: Urine neutrophil gelatinaseassociated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol. 2009; 20(8): 1823-32.
41. Parikh CR, Abraham E, Ancukiewicz M, et al.: Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol. 2005; 16(10): 3046-52.
42. Doi K, Negishi K, Ishizu T, et al.: Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med. 2011; 39(11): 2464-9.
43. Nejat M, Pickering JW, Walker RJ, et al.: Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care. 2010; 14(3): R85.
44. Srisawat N, Wen X, Lee M, et al.: Urinary biomarkers and renal recovery in critically ill patients with renal support. Clin J Am Soc Nephrol. 2011; 6(8): 1815-23.
45. Koyner JL, Shaw AD, Chawla LS, et al.: Tissue Inhibitor Metalloproteinase-2 (TIMP-2)·IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI. J Am Soc Nephrol. 2015; 26(7): 1747-54.
46. Smith GL, Lichtman JH, Bracken MB, et al.: Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006; 47(10): 1987-96.
47. Brisco MA, Testani JM: Novel renal biomarkers to assess cardiorenal syndrome. Curr Heart Fail Rep. 2014; 11(4): 485-99.
48. Damman K, Masson S, Hillege HL, et al.: Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J. 2011; 32(21): 2705-12.
49. Damman K, van Veldhuisen DJ, Navis G, et al.: Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart. 2010; 96(16): 1297-302.
50. Jungbauer CG, Birner C, Jung B, et al.: Kidney injury molecule-1 and N-acetyl-β-d-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome. Eur J Heart Fail. 2011; 13(10): 1104-10.
51. Maisel AS, Mueller C, Fitzgerald R, et al.: Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail. 2011; 13(8): 846-51.
52. Shrestha K, Borowski AG, Troughton RW, et al.: Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure. J Card Fail. 2011; 17(6): 472-8.
53. van Deursen VM, Damman K, Voors AA, et al.: Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure. Circ Heart Fail. 2014; 7(1): 35-42.
54. Moledina DG, Parikh CR, Garg AX, et al.: Association of Perioperative Plasma Neutrophil Gelatinase-Associated Lipocalin Levels with 3-Year Mortality after Cardiac Surgery: A Prospective Observational Cohort Study. PLoS One. 2015; 10(6): e0129619.
55. Hall IE, Yarlagadda SG, Coca SG, et al.: IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol. 2010; 21(1): 189-97.
56. Parikh CR, Jani A, Mishra J, et al.: Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006; 6(7): 1639-45.
57. Reese PP, Hall IE, Weng FL, et al.: Associations between Deceased-Donor Urine Injury Biomarkers and Kidney Transplant Outcomes. J Am Soc Nephrol. 2016; 27(5): 1534-43.
58. Hall IE, Doshi MD, Reese PP, et al.: Association between peritransplant kidney injury biomarkers and 1-year allograft outcomes. Clin J Am Soc Nephrol. 2012; 7(8): 1224-33.
59. Nauta FL, Bakker SJ, van Oeveren W, et al.: Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients. Am J Kidney Dis. 2011; 57(5): 733-43.
60. Hall IE, Coca SG, Perazella MA, et al.: Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis. Clin J Am Soc Nephrol. 2011; 6(12): 2740-9.
61. Liangos O, Perianayagam MC, Vaidya VS, et al.: Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol. 2007; 18(3): 904-12.
62. Nejat M, Pickering JW, Devarajan P, et al.: Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int. 2012; 81(12): 1254-62.
63. Singer E, Elger A, Elitok S, et al.: Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int. 2011; 80(4): 405-14.
64. Srisawat N, Murugan R, Lee M, et al.: Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following communityacquired pneumonia. Kidney Int. 2011; 80(5): 545-52.
65. Kwon O, Ahn K, Zhang B, et al.: Simultaneous monitoring of multiple urinary cytokines may predict renal and patient outcome in ischemic AKI. Ren Fail. 2010; 32(6): 699-708.
66. Nickolas TL, Schmidt-Ott KM, Canetta P, et al.: Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol. 2012; 59(3): 246-55.
67. Lee CG, Kim JG, Kim HJ, et al.: Discovery of an integrative network of microRNAs and transcriptomics changes for acute kidney injury. Kidney Int. 2014; 86(5): 943-53.
68. Ramachandran K, Saikumar J, Bijol V, et al.: Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury. Clin Chem. 2013; 59(12): 1742-52.
69. Saikumar J, Hoffmann D, Kim TM, et al.: Expression, circulation, and excretion profile of microRNA-21,-155, and-18a following acute kidney injury. Toxicol Sci. 2012; 129(2): 256-67.
70. Whitaker RM, Stallons LJ, Kneff JE, et al.: Urinary mitochondrial DNA is a biomarker of mitochondrial disruption and renal dysfunction in acute kidney injury. Kidney Int. 2015; 88(6): 1336-44.
71. Pepe MS, Etzioni R, Feng Z, et al.: Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001; 93(14): 1054-61.
72. Pitt B, Pfeffer MA, Assmann SF, et al.: Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014; 370(15): 1383-92.
73. Koyner JL, Parikh CR: Clinical utility of biomarkers of AKI in cardiac surgery and critical illness. Clin J Am Soc Nephrol. 2013; 8(6): 1034-42.
74. Huen SC, Parikh CR: Molecular phenotyping of clinical AKI with novel urinary biomarkers. Am J Physiol Renal Physiol. 2015; 309(5): F406-13.